EU approves Sanofi drug for chronic lung disease
The European Union has approved Sanofi’s blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday. The debilitating disease, sometimes called “smoker’s lungs”,
